Home › Therapeutic areas › Oncology › Merkel Cell Carcinoma
Merkel Cell Carcinoma (2 companies)
Companies with an active program in Merkel Cell Carcinoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| PHIO | Phio Pharmaceuticals | Oncology | 1 | Phase 1 | $9.6M | 4 |
| HURA | TuHURA Biosciences | Oncology | 2 | Phase 3 | $104M | 4 |
No companies match.